合計 50 件の最近のインサイダー取引記録が記録されています TScan Therapeutics, Inc. (TCRX), 内訳は 44 件の買い および 1 件の売り. インサイダー買い総額は $23.55M インサイダー売り総額は $952.12K.
最近活動のある主要インサイダーには Amello Jason, Macbeath Gavin, Zdraveski Zoran. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — TCRX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-01-20 |
Amello Jason |
Chief Financial Officer |
RSU 付与（制限付株式） |
350,000 |
$1.12 |
$392K |
350,000 |
| 2026-01-20 |
Macbeath Gavin |
Chief Executive Officer |
RSU 付与（制限付株式） |
1,165,000 |
$1.12 |
$1.3M |
1,165,000 |
| 2026-01-20 |
Zdraveski Zoran |
See Remarks |
RSU 付与（制限付株式） |
350,000 |
$1.12 |
$392K |
350,000 |
| 2026-01-20 |
Dworak Leiden |
See Remarks |
RSU 付与（制限付株式） |
100,000 |
$1.12 |
$112K |
100,000 |
| 2026-01-20 |
Louis Chrystal |
Chief Medical Officer |
RSU 付与（制限付株式） |
420,000 |
$1.12 |
$470.4K |
420,000 |
| 2025-12-23 |
Lynx1 Capital Management Lp |
10 Percent Owner |
情報に基づく買い |
6,232 |
$0.90 |
$5.6K |
8,019,148 |
| 2025-12-22 |
Lynx1 Capital Management Lp |
10 Percent Owner |
情報に基づく買い |
75,500 |
$0.90 |
$67.95K |
8,012,916 |
| 2025-12-19 |
Lynx1 Capital Management Lp |
10 Percent Owner |
情報に基づく買い |
80,069 |
$0.90 |
$71.97K |
7,937,416 |
| 2025-08-14 |
Dworak Leiden |
Principal Accounting Officer |
不明 |
37,500 |
$2.90 |
$108.75K |
- |
| 2025-06-30 |
Baker Bros. Advisors Lp |
Director |
RSU 付与（制限付株式） |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-06-30 |
Dorton Katina |
Director |
RSU 付与（制限付株式） |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-06-30 |
Nicholson Garry A |
Director |
RSU 付与（制限付株式） |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-06-30 |
Klencke Barbara |
Director |
RSU 付与（制限付株式） |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-06-30 |
Gruia Gabriela |
Director |
RSU 付与（制限付株式） |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-06-30 |
Woods Keith |
Director |
RSU 付与（制限付株式） |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-05-20 |
Lynx1 Capital Management Lp |
10 Percent Owner |
情報に基づく買い |
1,200,000 |
$1.20 |
$1.44M |
7,946,141 |
| 2025-05-19 |
Lynx1 Capital Management Lp |
10 Percent Owner |
情報に基づく買い |
1,388,794 |
$1.20 |
$1.67M |
6,746,141 |
| 2025-01-03 |
Amello Jason |
Chief Financial Officer |
RSU 付与（制限付株式） |
270,000 |
$3.07 |
$827.55K |
270,000 |
| 2025-01-03 |
Macbeath Gavin |
Chief Executive Officer |
RSU 付与（制限付株式） |
800,000 |
$3.07 |
$2.45M |
800,000 |
| 2025-01-03 |
Zdraveski Zoran |
See Remarks |
RSU 付与（制限付株式） |
250,000 |
$3.07 |
$766.25K |
250,000 |
| 2025-01-03 |
Louis Chrystal |
Chief Medical Officer |
RSU 付与（制限付株式） |
400,000 |
$3.07 |
$1.23M |
400,000 |
| 2024-12-26 |
Lynx1 Capital Management Lp |
10 Percent Owner |
情報に基づく買い |
7,500,000 |
$0.00 |
$750.00 |
7,500,000 |
| 2024-12-13 |
Lynx1 Capital Management Lp |
10 Percent Owner |
情報に基づく買い |
100,000 |
$2.90 |
$290.14K |
5,357,347 |
| 2024-12-12 |
Lynx1 Capital Management Lp |
10 Percent Owner |
情報に基づく買い |
31,800 |
$3.01 |
$95.63K |
5,257,347 |
| 2024-11-15 |
Lynx1 Capital Management Lp |
10 Percent Owner |
情報に基づく買い |
947 |
$4.34 |
$4.11K |
5,225,547 |
| 2024-09-23 |
Klencke Barbara |
Director |
情報に基づく買い |
5,000 |
$5.29 |
$26.45K |
45,000 |
| 2024-08-26 |
Klencke Barbara |
Director |
情報に基づく買い |
5,000 |
$5.53 |
$27.65K |
40,000 |
| 2024-08-23 |
Klencke Barbara |
Director |
情報に基づく買い |
5,000 |
$5.69 |
$28.45K |
35,000 |
| 2024-08-23 |
Zdraveski Zoran |
See Remarks |
情報に基づく売り |
164,686 |
$5.78 |
$952.12K |
4,716 |
| 2024-06-12 |
Baker Bros. Advisors Lp |
Director |
RSU 付与（制限付株式） |
47,500 |
$8.88 |
$421.8K |
47,500 |
| 2024-06-12 |
Dorton Katina |
Director |
RSU 付与（制限付株式） |
47,500 |
$8.88 |
$421.8K |
47,500 |
| 2024-06-12 |
Nicholson Garry A |
Officer |
不明 |
- |
- |
- |
- |
| 2024-06-12 |
Nicholson Garry A |
Director |
RSU 付与（制限付株式） |
23,750 |
$8.88 |
$210.9K |
23,750 |
| 2024-06-12 |
Klencke Barbara |
Director |
RSU 付与（制限付株式） |
47,500 |
$8.88 |
$421.8K |
47,500 |
| 2024-06-12 |
Gruia Gabriela |
Director |
RSU 付与（制限付株式） |
47,500 |
$8.88 |
$421.8K |
47,500 |
| 2024-06-12 |
Woods Keith |
Director |
RSU 付与（制限付株式） |
47,500 |
$8.88 |
$421.8K |
47,500 |
| 2024-05-01 |
Louis Chrystal |
Chief Medical Officer |
RSU 付与（制限付株式） |
380,000 |
$8.62 |
$3.28M |
380,000 |
| 2024-04-22 |
Louis Chrystal |
Officer |
不明 |
- |
- |
- |
- |
| 2024-04-19 |
Baker Bros. Advisors Lp |
Director |
情報に基づく買い |
825,968 |
$0.00 |
$82.60 |
4,018,678 |
| 2024-04-19 |
Lynx1 Capital Management Lp |
10 Percent Owner |
情報に基づく買い |
5,000,000 |
$0.00 |
$500.00 |
5,000,000 |
| 2024-02-01 |
Amello Jason |
Chief Financial Officer |
RSU 付与（制限付株式） |
750,000 |
$5.15 |
$3.86M |
750,000 |
| 2024-01-29 |
Amello Jason |
Officer |
不明 |
- |
- |
- |
- |
| 2024-01-12 |
Macbeath Gavin |
Chief Executive Officer |
RSU 付与（制限付株式） |
160,000 |
$6.00 |
$960K |
160,000 |
| 2024-01-12 |
Zdraveski Zoran |
See Remarks |
RSU 付与（制限付株式） |
52,500 |
$6.00 |
$315K |
52,500 |
| 2024-01-12 |
Dworak Leiden |
Other: Vice President, Finance |
RSU 付与（制限付株式） |
46,875 |
$6.00 |
$281.25K |
46,875 |
| 2023-12-19 |
Barberich Timothy J |
Director |
情報に基づく買い |
317 |
$4.97 |
$1.58K |
67,027 |
| 2023-12-18 |
Barberich Timothy J |
Director |
情報に基づく買い |
28,830 |
$4.89 |
$140.88K |
66,710 |
| 2023-12-14 |
Klencke Barbara |
Director |
情報に基づく買い |
5,000 |
$5.08 |
$25.4K |
30,000 |
| 2023-12-06 |
Woods Keith |
Officer |
不明 |
- |
- |
- |
- |
| 2023-12-06 |
Woods Keith |
Director |
RSU 付与（制限付株式） |
17,500 |
$6.74 |
$117.95K |
17,500 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
